EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments

Chiara Lago iD, Aniello Federico, Gloria Leva iD, Norman L Mack, Benjamin Schwalm, Claudio Ballabio iD, Matteo Gianesello iD, Luana Abballe, Isabella Giovannoni iD, Sofia Reddel, Sabrina Rossi, Nicolas Leone iD und 9 weitere

EMBO Molecular Medicine · 07.12.2023 · 15 (12)

DOI: 10.15252/emmm.202318199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 30.11.2023. Verfasst von Chiara Lago und 20 weiteren Autor:innen. Beteiligte Einrichtung: Armenise-Harvard Laboratory of Brain Disorders and Cancer, CIBIO, Trento, Italy. Hauptthemen laut MEDLINE: Biological Specimen Banks, Brain Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Accelerator Award - Cancer Research UK/AIRC - INCAR project, AIRC-Special Project 5×1000, Fondazione Cassa Di Risparmio Di Trento E Rovereto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain tumors are the leading cause of cancer‐related death in children. Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of pediatric brain cancers are limited and hard to establish. We present a protocol that enables efficient generation, expansion, and biobanking of pediatric brain cancer organoids. Utilizing our protocol, we have established patient‐derived organoids (PDOs) from ependymomas, medulloblastomas, low‐grade glial tumors, and patient‐derived xenograft organoids (PDXOs) from medulloblastoma xenografts. PDOs and PDXOs recapitulate histological features, DNA methylation profiles, and intratumor heterogeneity of the tumors from which they were derived. We also showed that PDOs can be xenografted. Most interestingly, when subjected to the same routinely applied therapeutic regimens, PDOs respond similarly to the patients. Taken together, our study highlights the potential of PDOs and PDXOs for research and translational applications for personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological Specimen BanksBrain NeoplasmsHumansChildHeterograftsOrganoids

Stichwörter der Autor:innen

brain tumorsorganoidspatient-derivedpediatric cancertranslational applications

Autor:innen und Institutionen

  • Armenise-Harvard Laboratory of Brain Disorders and Cancer, CIBIO, Trento, Italy.
  • Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Department of Onco-Hematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Rome, Italy.
  • Pathology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Neurosurgery Unit, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

ORCID-Profile: Chiara Lago, Gloria Leva, Claudio Ballabio, Matteo Gianesello, Isabella Giovannoni, Nicolas Leone, Alessandra Bisio, Alessia Soldano, Franco Locatelli, Marcel Kool, Evelina Miele, Luca Tiberi

Förderung

  • Accelerator Award - Cancer Research UK/AIRC - INCAR project
  • AIRC-Special Project 5×1000
  • Fondazione Cassa Di Risparmio Di Trento E Rovereto
  • European Molecular Biology Organization (EMBO)
  • Fondazione AIRC per la ricerca sul cancro ETS (AIRC)
  • Fondazione Heal
  • Fondazione Pezcoller
  • Giovanni Armenise-Harvard Foundation (GAHF)

Zitieren

APA

Lago, C., Federico, A., Leva, G., Mack, N. L., Schwalm, B., Ballabio, C., Gianesello, M., Abballe, L., Giovannoni, I., Reddel, S., Rossi, S., Leone, N., Carai, A., Mastronuzzi, A., Bisio, A., Soldano, A., Quintarelli, C., Locatelli, F., Kool, M., …, & Tiberi, L. (2023). Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments. EMBO Molecular Medicine, 15(12). https://doi.org/10.15252/emmm.202318199

Vancouver

Lago C, Federico A, Leva G, Mack NL, Schwalm B, Ballabio C, et al. Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments. EMBO Molecular Medicine. 2023;15(12). doi:10.15252/emmm.202318199

BibTeX
@article{Lago2023,
  author = {Lago, Chiara and Federico, Aniello and Leva, Gloria and Mack, Norman L and Schwalm, Benjamin and Ballabio, Claudio and Gianesello, Matteo and Abballe, Luana and Giovannoni, Isabella and Reddel, Sofia and Rossi, Sabrina and Leone, Nicolas and Carai, Andrea and Mastronuzzi, Angela and Bisio, Alessandra and Soldano, Alessia and Quintarelli, Concetta and Locatelli, Franco and Kool, Marcel and Miele, Evelina and Tiberi, Luca},
  title = {Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  volume = {15},
  number = {12},
  doi = {10.15252/emmm.202318199}
}
Kostenlos starten →